Prespecified secondary analysis of FINEARTS-HF (HFmrEF/HFpEF): finerenone's effect on cardiovascular death and total HF events was consistent across baseline heart rate in sinus rhythm (n=3497) and AF (n=2190); higher heart rate was linked to risk only in sinus rhythm.
Secondary analysis
Chimura et al. Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial